Pedro Pablo España

5.0k total citations
84 papers, 2.1k citations indexed

About

Pedro Pablo España is a scholar working on Epidemiology, Emergency Medicine and Infectious Diseases. According to data from OpenAlex, Pedro Pablo España has authored 84 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Epidemiology, 26 papers in Emergency Medicine and 24 papers in Infectious Diseases. Recurrent topics in Pedro Pablo España's work include Pneumonia and Respiratory Infections (55 papers), Emergency and Acute Care Studies (26 papers) and Pneumocystis jirovecii pneumonia detection and treatment (19 papers). Pedro Pablo España is often cited by papers focused on Pneumonia and Respiratory Infections (55 papers), Emergency and Acute Care Studies (26 papers) and Pneumocystis jirovecii pneumonia detection and treatment (19 papers). Pedro Pablo España collaborates with scholars based in Spain, United States and Peru. Pedro Pablo España's co-authors include José M. Quintana, Amaia Bilbao, Alberto Capelastegui, Inmaculada Gorordo, Cristóbal Esteban, Mikel Egurrola, A. Capelastegui, Ane Uranga, Antoní Torres and M. Ortega and has published in prestigious journals such as PLoS ONE, The Science of The Total Environment and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Pedro Pablo España

80 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pedro Pablo España Spain	23	1.6k	647	474	410	237	84	2.1k
Alberto Capelastegui Spain	25	1.3k 0.8×	548 0.8×	437 0.9×	551 1.3×	144 0.6×	51	1.9k
Albert Gabarrús Spain	31	2.0k 1.3×	410 0.6×	732 1.5×	863 2.1×	387 1.6×	99	3.0k
Fran Balamuth United States	27	1.4k 0.9×	518 0.8×	472 1.0×	299 0.7×	166 0.7×	98	2.5k
Frederic Manresa Spain	26	2.4k 1.5×	487 0.8×	702 1.5×	822 2.0×	304 1.3×	33	3.3k
María Bodi Spain	22	917 0.6×	227 0.4×	790 1.7×	526 1.3×	224 0.9×	89	2.1k
Rafael Zalacaín Spain	23	1.3k 0.9×	344 0.5×	421 0.9×	725 1.8×	191 0.8×	74	2.0k
Forest W. Arnold United States	21	946 0.6×	273 0.4×	239 0.5×	181 0.4×	226 1.0×	86	1.4k
José Blanquer Spain	25	1.1k 0.7×	241 0.4×	349 0.7×	339 0.8×	129 0.5×	63	1.7k
Javier Aspa Spain	24	1.2k 0.7×	252 0.4×	300 0.6×	353 0.9×	223 0.9×	55	1.8k
Ivan Le Jeune United Kingdom	11	1.0k 0.6×	412 0.6×	283 0.6×	973 2.4×	137 0.6×	17	2.1k

Countries citing papers authored by Pedro Pablo España

Since Specialization

Citations

This map shows the geographic impact of Pedro Pablo España's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Pablo España with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Pablo España more than expected).

Fields of papers citing papers by Pedro Pablo España

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro Pablo España. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Pablo España. The network helps show where Pedro Pablo España may publish in the future.

Co-authorship network of co-authors of Pedro Pablo España

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro Pablo España. A scholar is included among the top collaborators of Pedro Pablo España based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro Pablo España. Pedro Pablo España is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Urrechaga, Eloísa, Patricia Aspichueta, César Martı́n, et al.. (2025). Genetic Analysis and Predictive Modeling of COVID-19 Severity in a Hospital-Based Patient Cohort. Biomolecules. 15(3). 393–393. 1 indexed citations

España, Pedro Pablo, Ane Uranga, José M. Quintana, et al.. (2024). Effectiveness of bivalent mRNA booster vaccination and previous infection in older adults during Omicron period: real-world evidence. Age and Ageing. 53(11).

García-García, Fernando, Dae‐Jin Lee, Joaquín Martínez‐Minaya, et al.. (2023). Extracting relevant predictive variables for COVID-19 severity prognosis: An exhaustive comparison of feature selection techniques. PLoS ONE. 18(4). e0284150–e0284150. 7 indexed citations

Ruiz, Luis Alberto, Leyre Serrano Fernández, Sílvia Pérez-Fernández, et al.. (2023). Impact of severe lymphopenia on the early prediction of clinical outcome in hospitalized patients with pneumococcal community-acquired pneumonia. Infection. 51(5). 1319–1327. 6 indexed citations

Fernández, Leyre Serrano, Luis Alberto Ruiz, Sílvia Pérez-Fernández, et al.. (2023). Short- and long-term prognosis of patients with community-acquired Legionella or pneumococcal pneumonia diagnosed by urinary antigen testing. International Journal of Infectious Diseases. 134. 106–113. 1 indexed citations

España, Pedro Pablo, et al.. (2023). Impact of prior SARS-COV-2 infection and vaccination on COVID-19 hospital admission and mortality amongst nursing home residents. Aging Clinical and Experimental Research. 35(8). 1771–1778. 1 indexed citations

Menéndez, Rosario, Raúl Méndez, Paula González‐Jiménez, et al.. (2022). Early Recognition of Low-Risk SARS-CoV-2 Pneumonia. CHEST Journal. 162(4). 768–781. 5 indexed citations

Fernández, Leyre Serrano, Luis Alberto Ruiz, Sílvia Pérez-Fernández, et al.. (2022). Estimating the risk of bacteraemia in hospitalised patients with pneumococcal pneumonia. Journal of Infection. 85(6). 644–651. 2 indexed citations

Aburto, Myriam, José Javier Echevarría-Uraga, Susana García‐Gutiérrez, et al.. (2020). Complications and hospital admission in the following 90 days after lung cryobiopsy performed in interstitial lung disease. Respiratory Medicine. 165. 105934–105934. 18 indexed citations

10.

Uranga, Ane, Amaia Bilbao, José M. Quintana, et al.. (2020). Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia. BMC Pulmonary Medicine. 20(1). 261–261. 4 indexed citations

11.

Méndez, Raúl, Pedro Pablo España, Jordi Almirall, et al.. (2020). Early and late cardiovascular events in patients hospitalized for community-acquired pneumonia. Archivos de Bronconeumología. 56(9). 551–558. 13 indexed citations

12.

Méndez, Raúl, Rosario Menéndez, Catia Cillóniz, et al.. (2018). Initial Inflammatory Profile in Community-acquired Pneumonia Depends on Time since Onset of Symptoms. American Journal of Respiratory and Critical Care Medicine. 198(3). 370–378. 42 indexed citations

13.

España, Pedro Pablo, et al.. (2018). Evaluación ambiental de aguas residuales: estero y manglar el macho de la ciudad de Machala. 2(1). 1 indexed citations

14.

Capelastegui, Alberto, Rafael Zalacaín, Amaia Bilbao, et al.. (2014). Pneumococcal pneumonia: differences according to blood culture results. BMC Pulmonary Medicine. 14(1). 128–128. 24 indexed citations

15.

Capelastegui, Alberto, Pedro Pablo España, Amaia Bilbao, et al.. (2012). Etiology of community-acquired pneumonia in a population-based study: Link between etiology and patients characteristics, process-of-care, clinical evolution and outcomes. BMC Infectious Diseases. 12(1). 134–134. 58 indexed citations

16.

España, Pedro Pablo, Alberto Capelastegui, José M. Quintana, et al.. (2009). Prospective Comparison of Severity Scores for Predicting Clinically Relevant Outcomes for Patients Hospitalized With Community-Acquired Pneumonia. CHEST Journal. 135(6). 1572–1579. 90 indexed citations

17.

España, Pedro Pablo, Alberto Capelastegui, Inmaculada Gorordo, et al.. (2006). Development and Validation of a Clinical Prediction Rule for Severe Community-acquired Pneumonia. American Journal of Respiratory and Critical Care Medicine. 174(11). 1249–1256. 222 indexed citations

18.

Capelastegui, Alberto, et al.. (2004). Management of community-acquired pneumonia and secular trends at different hospitals. Respiratory Medicine. 99(3). 268–278. 15 indexed citations

19.

Capelastegui, Alberto, Pedro Pablo España, José M. Quintana, et al.. (2004). Improvement of Process‐of‐Care and Outcomes after Implementing a Guideline for the Management of Community‐Acquired Pneumonia: A Controlled Before‐and‐After Design Study. Clinical Infectious Diseases. 39(7). 955–963. 111 indexed citations

20.

Miravitlles, Marc, Rafael Vidal, Ana Bustamante, et al.. (1998). Usefulness of a national registry of alpha-1-antitrypsin deficiency. The Spanish experience. Respiratory Medicine. 92(10). 1181–1187. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact